Director/PDMR Shareholding

RNS Number : 0317D

Ergomed plc

14 February 2020

 

 PRESS RELEASE

Ergomed Plc

("Ergomed" or the "Company")

Directors' Dealings

Guildford, UK - 14 February 2020 - Ergomed plc (LSE: ERGO) ("Ergomed" or the "Company"), a company focused on providing specialised services to the pharmaceutical industry, announces the purchase of ordinary  shares of 1 pence each ("Shares") by four Directors of the Company.

PDMR	Position	Shares acquired	Purchase price (£)	Date of purchase	Resultant shareholding in the Company (Shares)
Rolf Soderstrom(1)	Non-Executive Director	10,000	4.56	11 February 2020	10,000
Dr Jim Esinhart	Non-Executive Director	10,000	4.56	11 February 2020	10,000
Ian Johnson	Non-Executive Director	10,000	4.56	11 February 2020	10,000
Lewis Cameron	Chief Operating Officer	10,910	4.56	12 February 2020	10,910

(1)   Note: includes Shares acquired by Linda Davey, being a person closely associated with Rolf Soderstrom.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Rolf Soderstrom
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each  GB00BN7ZCY67
b)	Nature of the transaction	Purchase of Shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		£4.56	5,000
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 5,000 ordinary shares of 1 pence each, purchase price of 456 pence per share Aggregated: £22,800.00
f)	Date of the transaction	11 February 2020
g)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Linda Davey
2	Reason for the notification
a)	Position/status	PCA with Rolf Soderstrom, Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each  GB00BN7ZCY67
b)	Nature of the transaction	Purchase of Shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		£4.56	5,000
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 5,000 ordinary shares of 1 pence each, purchase price of 456 pence per share Aggregated: £22,800.00
f)	Date of the transaction	11 February 2020
g)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jim Esinhart, PhD
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each  GB00BN7ZCY67
b)	Nature of the transaction	Purchase of Shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		£4.56	10,000
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 10,000 ordinary shares of 1 pence each, purchase price of 456 pence per share Aggregated: £45,600.00
f)	Date of the transaction	11 February 2020
g)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Ian Johnson
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BN7ZCY67
b)	Nature of the transaction	Purchase of Shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		£4.56	10,000
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 10,000 ordinary shares of 1 pence each, purchase price of 456 pence per share Aggregated: £45,600.00
f)	Date of the transaction	11 February 2020
g)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Lewis Cameron
2	Reason for the notification
a)	Position/status	Chief Operating Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BN7ZCY67
b)	Nature of the transaction	Purchase of Shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		£4.56	10,910
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 10,910 ordinary shares of 1 pence each, purchase price of 456 pence per share Aggregated: £49,749.60
f)	Date of the transaction	12 February 2020
g)	Place of the transaction	London Stock Exchange, AIM

ENDS

Enquiries:

Ergomed plc	Tel: [phone]
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited	Tel: [phone]
Freddie Barnfield / Huw Jeremy (Nominated Adviser)
James Black (Broker)
Consilium Strategic Communications - for UK enquiries	Tel: [phone]
Chris Gardner / Sue Stuart	[e-mail]
Matthew Neal / Olivia Manser

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical trials, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services business includes a full range of high-quality contract research and clinical trial management (CRO) services under the Ergomed brand together with an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and an internationally recognized specialist expertise in orphan drug development, under the PSR brand. For further information, visit: http://ergomedplc.com.

 

END

 

 

DSHKZGMZVDZGGZG